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The maintenance of meiotic prophase arrest in fully grown vertebrate oocytes depends on the activity of a Gs G-protein that activates adenylyl
cyclase and elevates cAMP, and in the mouse oocyte, Gs is activated by a constitutively active orphan receptor, GPR3. To determine whether the
action of luteinizing hormone (LH) on the mouse ovarian follicle causes meiotic resumption by inhibiting GPR3-Gs signaling, we examined the
effect of LH on the localization of Gαs. Gs activation in response to stimulation of an exogenously expressed β2-adrenergic receptor causes Gαs to
move from the oocyte plasma membrane into the cytoplasm, whereas Gs inactivation in response to inhibition of the β2-adrenergic receptor causes
Gαs to move back to the plasma membrane. However, LH does not cause a change in Gαs localization, indicating that LH does not act by
terminating receptor-Gs signaling.
© 2007 Elsevier Inc. All rights reserved.Keywords: Meiotic resumption; Oocyte maturation; Luteinizing hormone; Heterotrimeric G proteins; Follicle-enclosed oocytes; MouseIntroduction
Fully grown vertebrate oocytes are stored in the ovary for
prolonged periods, arrested at meiotic prophase by a pathway
requiring the activity of a Gs G-protein (Gallo et al., 1995;
Mehlmann et al., 2002; Kalinowski et al., 2004). In mouse
oocytes, Gs is activated by the receptor GPR3 (Mehlmann et al.,
2004; Ledent et al., 2005; Hinckley et al., 2005; Mehlmann,
2005a), and in rat oocytes, this function is served by the related
receptor GPR12 (Hinckley et al., 2005). Ligands for GPR3 and
GPR12 have not been definitively identified, although some
effects of sphingolipids have been reported (Uhlenbrock et al.,
2002; Ignatov et al., 2003; Hinckley et al., 2005). These
receptors show constitutive activity when expressed in a variety
of cell lines (Eggerickx et al., 1995; Tanaka et al., 2007), so if an
agonist is required for their activity, it would appear to be⁎ Corresponding author. Fax: +1 860 679 1269.
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GPR3 activates Gs even in isolated oocytes, and the level of Gs
activity is independent of the presence of the surrounding
somatic cells (Freudzon et al., 2005).
The primary adenylyl cyclase activated by Gs in mouse and
rat oocytes is AC3 (Horner et al., 2003), and the resulting
elevation of cAMP is essential for maintaining meiotic arrest
(Eppig, 1991). This pathway involves cAMP-dependent protein
kinase-mediated phosphorylation of the phosphatase CDC25B
and the kinase WEE1B, which in turn keeps CDC2A, the kinase
that directly controls the prophase-to-metaphase transition, in
the phosphorylated and inactive state (Ferrell, 1999; Duckworth
et al., 2002; Lincoln et al., 2002; Han et al., 2005).
Luteinizing hormone (LH) from the pituitary acts on the
ovarian follicle to cause the resumption of meiosis in the oocyte,
as well as ovulation (Eppig et al., 2004; Mehlmann, 2005b).
Within mouse and rat follicles, LH receptors are located in the
mural granulosa cells, and not in the cumulus cells that directly
surround the oocyte, or in the oocyte itself (see Eppig et al.,
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in the somatic cells of EGF-like proteins (Espey and Richards,
2002; Park et al., 2004; Ashkenazi et al., 2005; Shimada et al.,
2006), which by activating EGF receptors in the somatic cells,
leads to meiotic resumption (Dekel and Sherizly, 1985; Downs
et al., 1988; Park et al., 2004; Ashkenazi et al., 2005; Hsieh et
al., 2007). However, the links between EGF receptor activation
in the somatic cells and meiotic progression in the oocyte are
incompletely understood. In some way, LH signaling leads to a
decrease in cAMP in mouse and rat oocytes (Schultz et al.,
1983; Sela-Abramovich et al., 2006), and this cAMP decrease
appears to be required for the resumption of meiosis; mice
lacking the primary cAMP phosphodiesterase found in the
oocyte, PDE3A, produce oocytes with elevated cAMP, which
are ovulated in response to LH, but remain arrested in prophase
(Masciarelli et al., 2004).
Possible pathways by which LH action on the somatic cells
might decrease oocyte cAMP include decreasing the production
of cAMP by inhibition of GPR3-Gs-AC3 signaling, increasing
the degradation of cAMP by stimulation of cAMP phospho-
diesterase, or modulating transport of cAMP between the
cumulus cells and oocyte (Fig. 1). Here we examine the first of
these possibilities.
In Gpr3 knockout mice, ∼80–90% of oocytes in antral
follicles from prepubertal ovaries resume meiosis sponta-
neously, with only ∼10–20% remaining arrested in prophase
(Mehlmann et al., 2004; Ledent et al., 2005). The concept that
almost all oocytes in antral follicles would show meiotic
resumption if GPR3 signaling was turned off by LH action is
further supported by the finding that 93% of oocytes that were
isolated from such follicles and maintained in prophase arrest by
the addition of the phosphodiesterase inhibitor hypoxanthineFig. 1. Pathways by which luteinizing hormone action on the somatic cells of the
ovarian follicle might lead to decreased cAMP in the oocyte, thus initiating the
prophase-to-metaphase transition. This paper tests the hypothesis that LH
signaling could inhibit cAMP production in the oocyte by inhibiting the
receptor-Gs-adenylyl cyclase system in the oocyte (GPR3-Gs-AC3). Alterna-
tively, LH signaling could stimulate cAMP degradation by stimulating cAMP
phosphodiesterase (PDE3A) or could modulate transport of cAMP between the
cumulus cells and oocyte through gap junctions, which are comprised at least
mostly of connexin 37 subunits (GJA4) (Simon et al., 1997; Kidder and Mhawi,
2002; Veitch et al., 2004).resumed meiosis when injected with a morpholino oligonucleo-
tide targeting Gpr3 (Hinckley et al., 2005). Injection of follicle-
enclosed oocytes with siRNA targeting Gpr3 also causes
meiotic resumption in the majority of oocytes (Mehlmann,
2005a). When Gs is turned off experimentally, by injecting
follicle-enclosed mouse oocytes with an inhibitory antibody or a
dominant negative form of Gαs, nuclear envelope breakdown
and polar body formation occur (Mehlmann et al., 2002;
Kalinowski et al., 2004), and likewise mice lacking Adcy3 show
spontaneous resumption of meiosis (Horner et al., 2003). All of
these observations indicate that inhibition of the GPR3-Gs-AC3
pathway is a plausible mechanism by which LH might cause
meiotic resumption. Specifically, LH-induced signaling from
the mural granulosa cells could cause the cumulus cells to
release a GPR3 antagonist onto the oocyte, or in some way
could reduce the production of a GPR3 agonist in the oocyte.
Testing the hypothesis that LH signaling in the somatic cells
results in a decrease in Gs activity in the oocyte presents the
challenge of measuring Gs activity while the oocyte remains
enclosed within the multilayered complex of somatic cells. If
the somatic cells are removed from the oocyte, cAMP decreases
(Törnell et al., 1990), and meiosis resumes spontaneously
(Pincus and Enzmann, 1935). In order to avoid this problem, we
used an optical method.
In various cell types including mouse oocytes (Freudzon et
al., 2005), receptor-mediated activation of Gs causes its α
subunit to translocate from the plasma membrane to the
cytoplasm (Marrari et al., 2007), which is due at least in part
to depalmitoylation of Gαs (Wedegaertner and Bourne, 1994;
Iiri et al., 1996; Thiyagarajan et al., 2002). The translocation of
Gαs has been detected by subcellular fractionation (Rasenick et
al., 1984; Levis and Bourne, 1992), immunostaining (Wede-
gaertner et al., 1996; Thiyagarajan et al., 2002; Freudzon et al.,
2005), and most recently by use of fluorescent fusion proteins
(Yu and Rasenick, 2002; Hynes et al., 2004; Allen et al., 2005;
Freudzon et al., 2005). The GαsGFP constructs used to monitor
Gαs internalization in response to adrenergic receptor agonists
also activate adenylyl cyclase in response to these agonists (Yu
and Rasenick, 2002; Hynes et al., 2004). Gαs is then
repalmitoylated (Jones et al., 1997), associates with intracellular
vesicles (Hynes et al., 2004), and is transported back to the
plasma membrane (Wedegaertner et al., 1996). Thus, if receptor
stimulation is terminated, Gαs re-accumulates on the plasma
membrane (Wedegaertner et al., 1996). In the experiments to be
described, we examine whether LH application to follicle-
enclosed mouse oocytes causes Gαs to accumulate in the oocyte
plasma membrane.
Materials and methods
Follicle and oocyte isolation and culture
Ovaries were dissected from 22- to 27-day-old C57BL/6×SJL F1 hybrid
mice (The Jackson Laboratory, Bar Harbor, ME), and preantral follicles
(140–180 μm diameter) or antral follicles (320–360 μm) were isolated using
fine forceps or 30-gauge needles. All manipulations were performed in MEMα
medium (#12000-022, Invitrogen, Carlsbad, CA) with 25 mM NaHCO3,
75 μg/ml penicillin G, 50 μg/ml streptomycin sulfate, and 5–10% FBS
242 R.P. Norris et al. / Developmental Biology 310 (2007) 240–249(#16000-044, Invitrogen). For experiments in which follicles were cultured for
24 h, the medium also contained 10 ng/ml ovine FSH (National Hormone and
Peptide Program) and insulin–transferrin–sodium selenite medium supplement
(Sigma Chemical Co., St. Louis, MO). Follicles were cultured on Millicell
culture plate inserts (PICMORG50, Millipore Corp., Bedford, MA) in 35-mm
dishes of medium, at 37 °C, with 5% CO2 in air. For experiments involving
LH, the mice were injected with 3–5 IU of equine chorionic gonadotropin
(eCG) 42–44 h before ovary isolation, to stimulate the expression of LH
receptors (eCG and ovine LH were obtained from the National Hormone and
Peptide Program, Torrance, CA). The antral follicles dissected from eCG-
primed mice were 360–570 μm in diameter.
Where indicated, oocytes were isolated from preantral follicles using 30-
gauge needles and a mouth-controlled pipet with an opening slightly smaller
than the oocyte diameter. The oocytes were cultured in 200 μl drops of
MEMα+5% FBS under light mineral oil (Fisher Scientific, Pittsburgh, PA).
Microinjection
Microinjections were performed using a chamber in which the oocyte or
follicle was held between 2 coverslips separated by double stick tape (1 layer for
oocytes and preantral follicles, 2 layers for antral follicles, resulting in spacers of
100 μm and 200 μm, respectively) (see Jaffe and Terasaki, 2004; Jaffe et al., in
press; Supplementary video 1). The injection volumes were quantitated as
previously described (Jaffe and Terasaki, 2004); the volume of the oocyte was
considered to be 200 pl.
GαsGFP localization
RNAs encoding GαsGFP and the rat β2-adrenergic receptor were
transcribed in vitro and post-translationally polyadenylated (see Aida et al.,
2001; Freudzon et al., 2005). The amounts injected per oocyte were 3 pg and
30 fg, respectively. After injection, the oocytes were cultured for∼24 h, to allow
GαsGFP expression. Under these conditions, the amount of GαsGFP protein in
the oocytes was comparable to the amount of endogenous Gαs (Freudzon et al.,
2005). For imaging, isolated oocytes were placed in 10 μl droplets of medium on
a coverslip-bottomed dish (P35G-0-20-C-INV, MatTek Corp., Ashland, MA)
under oil, and transferred to droplets containing 10 μM isoproterenol or 10 μM
propranolol (both from Sigma Chemical Co.), as indicated.
GαsGFP was imaged using a Zeiss 510 confocal microscope with a 40×/
0.8 NA water immersion lens contacting the bottom surface of the dish
(Freudzon et al., 2005). The dish was perfused with water-saturated 5% CO2/air,
and was maintained at ∼30 °C by use of a heated stage; it was impractical to
keep the dish at 37 °C, due to the contact between the dish and the immersion
lens. Thus, it is possible that the return of Gαs to the plasma membrane at 37 °C
is somewhat more rapid than determined here. However, such a temperature
effect would, if anything, strengthen the conclusion (see Results) that an LH-
induced change in Gαs distribution would have occurred sufficiently rapidly to
be detectable at 2–3 h after LH application. Plasma membrane : cytoplasm ratios
were determined using Metamorph software (Freudzon et al., 2005).
Gαs immunofluorescence
For experiments involving expression of β2 adrenergic receptors, antral
follicles were dissected from unprimed mice, and injected with 30 fg of RNA
encoding the rat β2 adrenergic receptor (see above). After RNA injection, the
follicles were cultured for 24 h on Millicell membranes. For experiments
involving LH, antral follicles were dissected from ovaries of eCG-primed mice,
and placed on Millicell membranes. Isoproterenol, propranolol, or LH were
applied by exchanging the medium underlying the Millicell membranes, and
after the indicated times, the follicles were collected from the membranes and
placed in 4% paraformaldehyde (Electron Microscopy Sciences, Fort Washing-
ton, PA) in PBS at 4 °C.
After 2 h, the follicles were rinsed in PBS and embedded in 3% low gelling
temperature agarose (SeaPlaque #50102; American Bioanalytical, Natick, MA).
This was accomplished by placing them in 2.0-ml polypropylene tubes with
conical bottoms (#72.693.005, Sarstedt Inc., Newton, NC), adding 1 ml of
melted agarose at 50 °C, and stirring slightly with a toothpick. After solidifyingthe agarose by placing the tubes on ice for 1 h, the tips of the tubes were cut off
with a razor blade, and the agarose blocks containing ∼6–10 follicles were
trimmed and placed in 30% sucrose at 4 °C. After 1–2 h, the blocks were
transferred to freezing medium (#H-TFM, Triangle Biomedical Sciences, Inc.,
Durham, NC) in 6-mm-diameter gelatin capsules (#5214, Ernest F. Fullam, Inc.,
Latham, NY). The samples were frozen in isopentane cooled with dry ice, and
8–10 μm sections were cut using a cryostat, and collected on SuperFrost Plus
glass slides (Fisher Scientific).
The sections were stained with an affinity purified antibody made against the
C-terminal decapeptide of Gαs, which recognizes Gαs in oocytes with high
specificity (RM, 3–6 μg/ml; Simonds et al., 1989; Freudzon et al., 2005). The
RM antibody was provided by T.L.Z. Jones (National Institutes of Health,
Bethesda MD). The sections were imaged with a Pascal confocal microscope,
with a 40×/1.2 NA objective (Carl Zeiss, Inc., Thornwood, NY). Other
conditions were as previously described (Freudzon et al., 2005). Plasma
membrane and cytoplasmic fluorescence intensities were measured using
MetaMorph software (Molecular Devices Corp., Downingtown, PA), and ratios
were calculated after subtraction of background values obtained from sections
stained with nonimmune IgG and processed in parallel (see Freudzon et al.,
2005).
Evaluation of the kinetics of nuclear envelope breakdown in
follicle-enclosed oocytes stimulated with LH or Gs inhibitory antibody
To determine the time course of nuclear envelope breakdown following LH
application, antral follicles from eCG-primed mice were placed on Millicell
culture plates, and exposed to 1 μg/ml LH. At various times after LH
application, cumulus–oocyte complexes were dissected from the follicles, and
cumulus cells were stripped from the oocytes using a mouth-controlled pipet, to
score for the presence or absence of a prophase nucleus. Only oocytes from
compact cumulus–oocyte complexes were included.
To determine the time course of nuclear envelope breakdown following
injection of the Gs inhibitory antibody (RM), follicle-enclosed oocytes from
unprimed mice were first placed in a microinjection chamber and injected with
10 pl of a 10 mg/ml stock of the antibody in PBS. This resulted in a final
concentration of 500 μg/ml=3.3 μM of IgG in the oocyte. The follicles were
then placed on Millicell culture plates held in a 35 mm dish, with a volume of
1.2–1.6 ml of medium beneath the membrane. This volume resulted in only a
thin film of medium on top of each follicle, thus slightly flattening the follicle,
and allowing the nucleus and nucleoli to be clearly visualized using an upright
microscope with a long working distance 20×/0.4 NA objective. (It should be
noted that this simple and physiologically unperturbing observation method
cannot be used with follicles from eCG-primed mice, because such follicles are
not as optically clear). The dishes were maintained at 34–36 °C in an
environment of water-saturated 5% CO2/air, except during brief (∼1 min)
observation periods. Only one injected follicle and one uninjected control
follicle were placed together on an individual Millicell membrane, to minimize
the time outside of the incubator needed for observation. The time of nuclear
envelope breakdown was considered to be halfway between the last time point at
which the nuclear envelope and nucleoli were visible, and the first time point at
which they had disappeared. The time between these two observation points was
12–25 min.
Results
Kinetics of Gαs movement between the oocyte plasma
membrane and cytoplasm in response to receptor activation
and inactivation
In a previous study (Freudzon et al., 2005), we established
that localization of Gαs can be used as an indicator of receptor
activation of Gs in follicle-enclosed mouse oocytes. In the
absence of the Gs-activating receptor, GPR3, Gαs is primarily
associated with the oocyte plasma membrane, and GPR3
expression causes Gαs to move into the oocyte cytoplasm. This
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cence and by expression of GαsGFP in live oocytes. However,
these observations, made by comparing wild type or Gpr3−/−
oocytes, or Gpr3−/− oocytes after injection of Gpr3 RNA, did
not provide information about the kinetics of Gαs movement
between the plasma membrane and cytoplasm in response to
receptor activation and inactivation. Such kinetic information is
needed in order to use Gαs localization to monitor the possible
effect of LH action on Gs activity.
To examine these kinetics, we would have ideally liked to
investigate the effect of agonists and antagonists of GPR3 on theFig. 2. Translocation of GαsGFP in oocytes in response to activation and inactivation
preantral follicles, and injected with RNAs encoding GαsGFP and the rat β2-adrenerg
an oocyte in which the β2-adrenergic receptor was activated with 10 μM isoprotereno
washed out and replaced with 10 μMpropranolol. In panels A and B, the black areas w
one or both are visible, depending on the optical section. Because the oocytes use
prophase arrested throughout the entire period. GαsGFP was expressed at a level co
significant autofluorescence in oocytes without GαsGFP and imaged under identical c
fluorescence ratios as a function of time, for the oocyte illustrated in panels A and B
receptor, but without agonist stimulation, was 6.1±0.5 (mean±SEM, n=6), which
exogenous receptor expression (8.8±0.8, n=19) (Freudzon et al., 2005), perhaps due
al., 1994). At 30 min after isoproterenol application, the mean plasma membrane : ctime course of Gαs relocalization. However, ligands for GPR3
have not been clearly identified, and the only proposed
candidates, sphingosine 1-phosphate and dihydrosphingosine
1-phosphate, have small effects (Uhlenbrock et al., 2002). As an
alternative, we used an exogenously expressed Gs-activating
receptor, the β2-adrenergic receptor, to change Gαs localization
in response to receptor activation and inactivation. β2-
adrenergic receptor activation caused Gαs to move into the
oocyte cytoplasm, as monitored with GαsGFP (see Freudzon et
al., 2005, Supplementary material, and Fig. 2A of the present
paper). β2-Adrenergic receptor inactivation caused GαsGFP toof an exogenously expressed β2 adrenergic receptor. Oocytes were isolated from
ic receptor. (A) GαsGFP movement from the plasma membrane to cytoplasm in
l. (B) GαsGFP movement back to the plasma membrane when isoproterenol was
ithin the oocyte are the nucleus and an oil drop introduced by the microinjection;
d for these experiments were obtained from preantral follicles, they remained
mparable to that of endogenous Gαs (see Freudzon et al., 2005). There was no
onditions (see Freudzon et al., 2005). (C) Plasma membrane : cytoplasm GαsGFP
. The mean ratio for GαsGFP in isolated oocytes expressing the β2-adrenergic
is slightly smaller than that reported previously for isolated oocytes without
to some degree of constitutive activity of the β2-adrenergic receptor (Chidiac et
ytoplasm fluorescence ratio was 2.1±0.1 (n=6).
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experiments, we used prophase-arrested oocytes that had been
isolated from preantral follicles, rather than those from antral
follicles, to prevent spontaneous resumption of meiosis in
culture. We injected RNA encoding the β2-adrenergic receptor,
along with RNA encoding GαsGFP; ∼24 h later, we imaged
GαsGFP as a function of time after applying a β2-adrenergic
receptor agonist (isoproterenol), followed by an antagonist
(propranolol) (Figs. 2A and B).
In response to 10 μM isoproterenol, GαsGFP moved into the
cytoplasm with a half time of 6±1 min (mean±SEM, n=6)
(Fig. 2C). After exchanging the medium to wash out isopro-Fig. 3. Translocation of endogenous Gαs in antral follicle-enclosed oocytes in resp
receptor. (A) Immunofluorescence image of a cryosection of an antral follicle labeled
cells, mural granulosa cells, and theca cells. The black space within the oocyte cytop
and the cumulus cells is the fluid-filled antrum. For immunoblots demonstrating antib
in sections stained with nonimmune IgG, see Freudzon et al. (2005). (B) A magnified
follicle-enclosed oocyte expressing the β2-adrenergic receptor and treated for 1 h with
imaging. (D) An antral follicle-enclosed oocyte expressing the β2-adrenergic recepto
propranolol, then fixed and cryosectioned for Gαs immunofluorescence imaging. (E)
enclosed oocytes for each of the conditions shown in the images above the graph (m
0.11); β2-AR+ISO+PROP (2.7±0.21). The value for β2-AR+ISO is statistically di
β2-AR+ISO+PROP is not different from the value for no β2-AR (p=0.13). (Not
oocytes in Fig. 2 are artifactually higher than those seen in the physically section
(Freudzon et al., 2005).)terenol and to add 10 μM propranolol, the time for the plasma
membrane : cytoplasm fluorescence ratio to return to a value
halfway between those before and after applying isoproterenol
was 67±3 min (n=4) (Fig. 2C). From this, we concluded that if
LH caused inactivation of the receptor (GPR3) that keeps Gs
active in the plasma membrane of antral follicle-enclosed
oocytes, this would result in an easily detectable change in Gαs
distribution within less than 1 h.
We also examined whether activation of the β2-adrenergic
receptor with isoproterenol would cause endogenous Gαs to
move into the oocyte cytoplasm, and whether subsequent
inactivation of this receptor with propranolol would cause aonse to activation and inactivation of an exogenously expressed β2 adrenergic
with an antibody against Gαs. Gαs is present in the oocyte, as well as the cumulus
lasm is the prophase nucleus. The black space between the mural granulosa cells
ody specificity, and for images illustrating the absence of significant fluorescence
view of the oocyte from another follicle like that shown in panel A. (C) An antral
10 μM isoproterenol, then fixed and cryosectioned for Gαs immunofluorescence
r and treated for 1 hour with 10 μM isoproterenol, followed by 1 h with 10 μM
Plasma membrane : cytoplasm Gαs immunofluorescence ratios in antral follicle-
ean±SEM, n=number of oocytes): no β2-AR (3.3±0.24); β2-AR+ISO (1.9±
fferent from both of the other values (unpaired t-test, pb0.04), but the value for
e that the absolute values of the ratios seen in the optical sections of isolated
ed specimens in this figure, due to an optical effect as previously described
Fig. 4. Determination of the time of nuclear envelope breakdown following LH
application to isolated antral follicles, or injection of a Gs inhibitory antibody
into follicle-enclosed oocytes. (A) Percentage of oocytes that have undergone
nuclear envelope breakdown at various times after treatment of antral follicles
with 1 μg/ml LH. Numbers in parentheses indicate the number of oocytes
scored for each point; results were obtained from 13 mice. (B) Transmitted light
image of an antral follicle-enclosed oocyte on a Millicell membrane, as used to
determine the time to nuclear envelope breakdown following injection of the
Gs-inhibitory antibody. (C) Nuclear envelope breakdown as a function of time
after injection of the Gs-inhibitory antibody. Each symbol represents an
individual oocyte.
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oocytes were injected with RNA encoding the β2-adrenergic
receptor, then incubated for 24 h to allow protein expression.
They were then treated with isoproterenol, or with isoproterenol
followed by propranolol, and then fixed, frozen, sectioned, and
stained for Gαs immunofluorescence imaging (Fig. 3).
The application of isoproterenol to follicle-enclosed oocytes
expressing the β2-adrenergic receptor caused the ratio of Gαs
immunofluorescence in the plasma membrane vs. cytoplasm to
decrease to 58% of that in the control oocytes without β2-
adrenergic receptor (Fig. 3). 60 min after washout of the
isoproterenol and addition of the propranolol, the ratio had
returned to 82% of that in the control. Although it was
impractical to use these methods to obtain a time course of the
return of Gαs to the plasma membrane following application of
propranolol, as we did for GαsGFP in live oocytes (Fig. 2),
these results showed that at 1 h, a statistically significant
relocation of Gαs was detectable (see Fig. 3 legend).
LH application to antral follicles does not cause a change in
Gαs localization
To determine if LH action inhibited Gs in antral follicle-
enclosed oocytes, we examined whether LH application to
isolated follicles caused Gαs to redistribute from the oocyte
cytoplasm to the plasma membrane, as seen with propranolol.
Follicles were cultured for 1–3 h with or without 1 μg/ml LH,
and then fixed and prepared for Gαs immunofluorescence.
These times for LH treatment were chosen because after 3 h
almost all oocytes have undergone nuclear envelope breakdown
(Fig. 4A).
Immunostaining for Gαs showed a plasma membrane :
cytoplasm fluorescence ratio in the oocyte that was not
significantly different for samples with or without LH treatment
for 1–3 h (Fig. 5). The lack of effect of LH on Gαs localization
is in contrast to the 3.7× increase in the ratio of Gαs
immunofluorescence in the plasma membrane : cytoplasm,
comparing oocytes with and without the GPR3 receptor
(Freudzon et al., 2005; see Fig. 5E). Thus, these results
indicated that LH action did not terminate the GPR3-mediated
activation of oocyte Gs, since this would have been expected to
cause Gαs to accumulate in the plasma membrane, if sufficient
time had elapsed between Gs inactivation and fixation such that
Gαs could have relocated (see Figs. 2 and 3).
Time between Gs inactivation and nuclear envelope breakdown
In order to interpret the results described above, we next
determined how much time would be required to cause nuclear
envelope breakdown, if LH acted by turning off Gs signaling.
To do this, we injected antral follicle-enclosed oocytes with an
affinity-purified antibody against the C-terminal 10 amino acids
of the α subunit of Gs that specifically recognizes the 52 and
45 kDa forms of Gαs present in mouse oocytes (Mehlmann et
al., 2002). This antibody inhibits the stimulation of adenylyl
cyclase activity in membranes from frog oocytes (Gallo et al.,
1995) as well as other cells (Simonds et al., 1989; Nair et al.,1990), in response to hydrolysis-resistant GTP analogs or β-
adrenergic receptor stimulation. These studies have shown that
binding of the antibody to the C-terminus of the GTP-bound
form of Gαs reduces its ability to stimulate adenylyl cyclase,
and have indicated that it may also interfere with the interaction
of Gαs with receptors. When injected into follicle-enclosed
mouse oocytes, the Gαs antibody decreases cAMP as measured
with a fluorescent indicator (unpublished results), and causes
meiotic resumption (Mehlmann et al., 2002).
After injection of the Gαs antibody, follicle-enclosed oocytes
were placed on optically clear Millicell membranes, such that
Fig. 5. Lack of translocation of Gαs in antral follicle-enclosed oocytes in response to LH. Panels A–D show immunofluorescence images of cryosections of antral
follicle-enclosed oocytes, labeled with an antibody against Gαs. (A) Oocyte in a follicle fixed without LH exposure. (B–D) Oocytes in follicles fixed after a 1-, 2-, or
3-h incubation with 1 μg/ml LH. Gαs is present in the oocyte plasma membrane as well as the cytoplasm, with a similar distribution with or without LH. (E) Plasma
membrane : cytoplasm Gαs immunofluorescence ratios in antral follicle-enclosed oocytes at 1–3 h after LH application, and in samples cultured in parallel without
LH (mean±SEM, n=number of oocytes). The results of 2–3 independent experiments for each time point were combined; in each experiment, we fixed follicles at a
single time point±LH. The plasma membrane : cytoplasm fluorescence ratios, without or with LH, were as follows: 1 h (3.29±0.14 vs. 3.18±0.17), 2 h (3.72±0.26
vs. 3.65± 0.30), 3 h (3.92±0.29 vs. 3.71±0.27). The values without or with LH were not significantly different for any of the time points (unpaired t-tests, pN0.5).
(F) For comparison, the plasma membrane: cytoplasm fluorescence ratios for Gαs immunofluorescence in preantral follicle-enclosed oocytes from Gpr3
+/+ and
Gpr3−/− mice (from Freudzon et al., 2005). For Gpr3+/+, the ratio was 3.6±0.3; for Gpr3−/−, the ratio was 13.4±1.3; these values are significantly different
(p=0.0001).
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methods). Under these conditions, the nuclear envelope and 1–2
nucleoli within the nucleus could be visualized (Fig. 4B) without
the use of glass coverslips, which can inhibit gas exchange. Of 8
injected oocytes, 6 underwent nuclear envelope breakdown at
67±5 min (mean±SEM) (Fig. 4C). (2 other oocytes did not
undergo nuclear envelope breakdown within a 3-h period of
observation.) 8/9 uninjected oocytes were prophase-arrested at
3 h, and a previous study has shown that injection of nonimmune
IgG does not cause nuclear envelope breakdown (Mehlmann et
al., 2002). From these observations, we determined that the time
between Gs inactivation and nuclear envelope breakdown is
∼1 h. Thus, if LH action had caused nuclear envelope
breakdown by terminating Gs activation, a change in Gαs
distribution should have been visible by the time of nuclear
envelope breakdown, based on the kinetics of the recycling of
Gαs to the plasma membrane shown in Figs. 2 and 3.Discussion
The maintenance of meiotic prophase arrest in follicle-
enclosed mouse oocytes depends on the constitutive activity of
the Gs-linked receptor GPR3 (Mehlmann et al., 2004; Ledent et
al., 2005; Hinckley et al., 2005; Mehlmann, 2005a), suggesting
that LH action on the mouse ovarian follicle could cause meiotic
resumption by way of terminating receptor-Gs signaling in the
oocyte. The experiments presented here argue against this
hypothesis. Gs activity was monitored by measuring the relative
distribution of Gαs in the oocyte plasma membrane and
cytoplasm. LH did not cause a change in this distribution,
under conditions where it would have been detected if GPR3-Gs
signaling had been turned off. One caveat is that the method we
used to monitor Gs activity would not have detected a transient
decrease, due to the delay in the response of the indicator, and
thus we can only conclude that LH does not cause the GPR3-Gs
247R.P. Norris et al. / Developmental Biology 310 (2007) 240–249pathway to inactivate and remain inactivated during the 3-h
duration of the experiment.
The kinetics of nuclear envelope breakdown following
experimental inhibition of Gs (Fig. 4C) show that if LH acted
by terminating GPR3-Gs signaling, the time of inhibition would
precede nuclear envelope breakdown by only ∼1 h. Nuclear
envelope breakdown occurs at ∼2–3 h after LH application
(Fig. 4A), indicating that if termination of GPR3-Gs signaling
was the cause of nuclear envelope breakdown, the inactivation
would have to occur at ∼1–2 h after LH application. However,
since the method we used to analyze Gs activity imposes a
delay of ∼1 h between the inhibition of Gs and the detectability
of a change in Gαs localization (Figs. 2 and 3), such a change
would not be expected to be detectable before 2–3 h after LH
application.
The only established means by which cellular Gs activity can
be regulated by extracellular signals is by way of regulation of a
Gs-linked receptor. Another class of proteins that regulate
heterotrimeric G-proteins, the cytoplasmic “RGS” proteins,
have not as yet been demonstrated to have any effect on Gs
activity (see Wieland et al., 2007), but in principle, such a
receptor-independent means of inhibiting Gs activity might
exist, and might not result in Gαs movement to the plasma
membrane. Our findings cannot exclude this possibility.
Nevertheless, the concept that LH causes the termination of
an ongoing supply of a GPR3 agonist, or causes the release of a
GPR3 antagonist, does not appear to account for the signal that
causes meiotic resumption in mouse oocytes.
Several other optical methods for measuring Gs activity are
available, but none of these appear to be applicable to follicle-
enclosed mouse oocytes. One such approach is based on the
change in localization of G protein-coupled receptors from
plasma membrane to cytoplasm, in response to activation
(Hynes et al., 2004). Another involves fluorescence resonance
energy transfer (FRET) between a YFP tag on a Gs-linked
receptor, and a CFP tag on a G protein γ subunit (Hein et al.,
2006). However, endogenous expression levels of the GPR3
receptor are ∼10× lower than can be detected by fluorescent
probes (Freudzon et al., 2005), and as a consequence of the low
expression level, specific antibodies for detecting native
amounts of GPR3 have not been found (unpublished results).
Thus neither of these methods could be used to study the effect
of LH on GPR3-Gs signaling at endogenous GPR3 expression
levels. Gs activity can also be monitored by measuring FRET
between its α and γ subunits (Hein et al., 2006), but the FRET
changes that have been detected with currently available probes
are too small for studying the LH response in the oocyte, due to
its slow time course. Thus further studies of possible regulation
of receptor-Gs signaling in the follicle-enclosed mouse oocyte
are likely to require the development of new optical techniques.
In a previous study, we established that LH does not cause
meiotic resumption in the mouse oocyte by activating a G-
protein of the Gi family, which inhibits adenylyl cyclase
(Mehlmann et al., 2006). LH action also does not require an
increase in oocyte Ca2+, which could in principle act to cause
meiotic resumption by inhibiting the Ca2+-sensitive enzyme
AC3 (Mehlmann et al., 2006). As illustrated in Fig. 1, two otherpossibilities for how LH signaling might lower oocyte cAMP
and stimulate meiotic resumption in mouse oocytes are stimu-
lation of cAMP phosphodiesterase in the oocyte (Eppig et al.,
1985; Richard et al., 2001; Han et al., 2006), or regulation of
cAMP flux through gap junctions with the somatic cells (see
Sela-Abramovich et al., 2006).
Although elevated cAMP is required to maintain meiotic
arrest (see Introduction), another unidentified factor from the
follicle cells is also required, since removal of oocytes from
their follicles causes meiotic resumption, even though GPR3/Gs
activity is not reduced by oocyte isolation (see Freudzon et al.,
2005). This unidentified factor could be cAMP, a regulator of
cAMP such as an inhibitor of PDE3A, or a molecule unrelated
to cAMP. Thus, it is also possible that LH acts by reducing the
activity of this unidentified follicle cell factor.
While a decrease in oocyte cAMP has been reported to occur
in response to LH receptor stimulation, prior to nuclear
envelope breakdown in both mouse and rat (Schultz et al.,
1983; Sela-Abramovich et al., 2006), such a decrease has not
been seen in hamster (Hubbard, 1986), and all of these
measurements are complicated by the issue that the oocytes
had to be removed from their follicles in order to carry out
radioimmunoassays. Thus, optical methods for measurement of
cAMP (see Nikolaev and Lohse, 2006) in live oocytes within
intact follicles would be very useful. The strongest evidence that
a decrease in cAMP is required for LH action is that mice
lacking the primary cAMP phosphodiesterase found in the
oocyte, PDE3A, produce oocytes with elevated cAMP, which
are ovulated in response to LH, but remain arrested in prophase
(Masciarelli et al., 2004). However, since basal cAMP is
elevated above the normal level in such oocytes, the lack of LH-
stimulated meiotic resumption in oocytes from Pde3a knockout
mice does not definitively show that a decrease in cAMP from
its normal basal level is a required step in LH signaling. The
possibility needs to be considered that LH in some way
bypasses the cAMP requirement for maintenance of meiotic
arrest, acting at a level closer to the CDC2A kinase that
regulates the prophase-to-metaphase transition.
Acknowledgments
We dedicate this paper to the late Richard D. Berlin, a
pioneer in the use of fluorescence microscopy to study
biological membranes, whose support was critical for these
studies. We thank Mark Rasenick for suggesting the idea of
using Gαs localization to investigate its activity in the oocyte,
and Cathy Berlot, Teresa Jones, Mark Terasaki, and John Eppig
for their interest and advice. We also thank Cathy Berlot for the
GαsGFP plasmid, Nick Ancellin for the β2-adrenergic receptor
plasmid, Teresa Jones for the Gαs antibody, A.F. Parlow
(National Hormone and Peptide Program, Torrance, CA) for
eCG, oLH, and oFSH, Mark Terasaki for his help in making the
movie of microinjection, and William Ratzan for technical
assistance. This work was supported by grants from the
National Institutes of Health to L.A. Jaffe (HD014939 and
DK073499), and to the Richard D. Berlin Center for Cell
Analysis and Modeling (RR022232).
248 R.P. Norris et al. / Developmental Biology 310 (2007) 240–249Appendix A. Supplementary online video
A supplementary video, showing microinjection of an antral
follicle-enclosed oocyte, can be found, in the online version, at
doi:10.1016/j.ydbio.2007.07.017.
References
Aida, T., Oda, S., Awaji, T., Yoshida, K., Miyazaki, S., 2001. Expression of a
green fluorescent protein variant in mouse oocytes by injection of RNAwith
an added long poly(A) tail. Mol. Hum. Reprod. 7, 1039–1046.
Allen, J.A., Yu, J.Z., Donati, R.J., Rasenick, M.M., 2005. β-Adrenergic receptor
stimulation promotes Gαs internalization through lipid rafts: a study in
living cells. Mol. Pharmacol. 67, 1493–1504.
Ashkenazi, H., Cao, X., Motola, S., Popliker, M., Conti, M., Tsafriri, A., 2005.
Epidermal growth factor family members: endogenous mediators of the
ovulatory response. Endocrinology 146, 77–84.
Chidiac, P., Hebert, T.E., Valiquette, M., Dennis, M., Bouvier, M., 1994. Inverse
agonist activity of β-adrenergic antagonists. Mol. Pharmacol. 45, 490–499.
Dekel, N., Sherizly, I., 1985. Epidermal growth factor induces maturation of rat
follicle-enclosed oocytes. Endocrinology 116, 406–409.
Downs, S.M., Daniel, S.A.J., Eppig, J.J., 1988. Induction of maturation in
cumulus cell-enclosed mouse oocytes by follicle-stimulating hormone and
epidermal growth factor: evidence for a positive stimulus of somatic cell
origin. J. Exp. Zool. 245, 86–96.
Duckworth, B.C., Weaver, J.S., Ruderman, J.V., 2002. G2 arrest in Xenopus
oocytes depends on phosphorylation of cdc25 by protein kinase A. Proc.
Natl. Acad. Sci. U. S. A. 99, 16794–16799.
Eggerickx, D., Denef, J.F., Labbe, O., Hayashi, Y., Refetoff, S., Vassart, G.,
Parmentier, M., Libert, F., 1995. Molecular cloning of an orphan G-protein-
coupled receptor that constitutively activates adenylate cyclase. Biochem. J.
309, 837–843.
Eppig, J.J., 1991. Maintenance of meiotic arrest and the induction of oocyte
maturation in mouse oocyte–granulosa cell complexes developed in vitro
from preantral follicles. Biol. Reprod. 45, 824–830.
Eppig, J.J., Ward-Bailey, P.F., Coleman, D.L., 1985. Hypoxanthine and
adenosine in murine ovarian follicular fluid: concentrations and activity in
maintaining oocyte meiotic arrest. Biol. Reprod. 33, 1041–1049.
Eppig, J.J., Wigglesworth, K., Pendola, F., Hirao, Y., 1997. Murine oocytes
suppress expression of luteinizing hormone receptor messenger ribonucleic
acid by granulosa cells. Biol. Reprod. 56, 976–984.
Eppig, J.J., Viveiros, M.M., Marin-Bivens, C., De La Fuente, R., 2004.
Regulation of mammalian oocyte maturation, In: Leung, P.C.K., Adashi,
E.Y. (Eds.), The Ovary, Second edition. Elsevier/Academic Press, San
Diego, pp. 113–129.
Espey, L.L., Richards, J.S., 2002. Temporal and spatial patterns of ovarian gene
transcription following an ovulatory dose of gonadotropin in the rat. Biol.
Reprod. 67, 1662–1670.
Ferrell, J.E., 1999. Xenopus oocyte maturation: new lessons from a good egg.
BioEssays 21, 833–842.
Freudzon, L., Norris, R.P., Hand, A.R., Tanaka, S., Saeki, Y., Jones, T.L.Z.,
Rasenick, M.M., Berlot, C.H., Mehlmann, L.M., Jaffe, L.A., 2005.
Regulation of meiotic prophase arrest in mouse oocytes by GPR3, a
constitutive activator of the Gs G protein. J. Cell Biol. 171, 255–265.
Gallo, C.J., Hand, A.R., Jones, T.L.Z., Jaffe, L.A., 1995. Stimulation of Xeno-
pus oocyte maturation by inhibition of the G-protein αs subunit, a
component of the plasma membrane and yolk platelet membranes. J. Cell
Biol. 130, 275–284.
Han, S.J., Chen, R., Paronetto, M.P., Conti, M., 2005. Wee1B is an oocyte-
specific kinase involved in the control of meiotic arrest in the mouse. Curr.
Biol. 15, 1670–1676.
Han, S.J., Vaccari, S., Nedachi, T., Andersen, C.B., Kovacina, K.S., Roth, R.A.,
Conti, M., 2006. Protein kinase B/Akt phosphorylation of PDE3A and its
role in mammalian oocyte maturation. EMBO J. 25, 5716–5725.
Hein, P., Rochais, R., Hoffmann, C., Dorsch, S., Nikolaev, V.O., Engelhardt, S.,
Berlot, C.H., Lohse, M.J., Bünemann, M., 2006. Gs activation is time-limiting in initiating receptor-mediated signaling. J. Biol. Chem. 281,
33345–33351.
Hinckley, M., Vaccari, S., Horner, K., Chen, R., Conti, M., 2005. The G-
protein-coupled receptors GPR3 and GPR12 are involved in cAMP sig-
naling and maintenance of meiotic arrest in rodent oocytes. Dev. Biol. 287,
249–261.
Horner, K., Livera, G., Hinckley, M., Trinh, K., Storm, D., Conti, M., 2003.
Rodent oocytes express an active adenylyl cyclase required for meiotic
arrest. Dev. Biol. 258, 385–396.
Hsieh, M., Lee, D., Panigone, S., Horner, K., Chen, R., Theologis, A., Lee, D.C.,
Threadgill, D.W., Conti, M., 2007. Luteinizing hormone-dependent
activation of the epidermal growth factor network is essential for ovulation.
Mol. Cell. Biol. 27, 1914–1924.
Hubbard, C.J., 1986. Cyclic AMP changes in the component cells of Graafian
follicles: possible influences on maturation in the follicle-enclosed oocytes
of hamsters. Dev. Biol. 118, 343–351.
Hynes, T.R., Mervine, S.M., Yost, E.A., Sabo, J.L., Berlot, C.H., 2004. Live
cell imaging of Gs and the β2-adrenergic receptor demonstrates that both αs
and β1γ7 internalize upon stimulation and exhibit similar trafficking
patterns that differ from that of the β2-adrenergic receptor. J. Biol. Chem.
279, 44101–44112.
Ignatov, A., Lintzel, J., Hermans-Borgmeyer, I., Kreienkamp, H.-J., Joost, P.,
Thomsen, S., Methner, A., Schaller, H.C., 2003. Role of the G-protein-
coupled receptor GPR12 as high-affinity receptor for sphingosylpho-
sphorylcholine and its expression and function in brain development.
J. Neurosci. 23, 907–914.
Iiri, T., Backlund, P.S., Jones, T.L.Z., Wedegaertner, P.B., Bourne, H.R., 1996.
Reciprocal regulation of Gsα by palmitate and the βγ subunit. Proc. Natl.
Acad. Sci. U. S. A. 93, 14592–14597.
Jaffe, L.A., Terasaki, M., 2004. Quantitative microinjection of oocytes, eggs,
and embryos. Methods Cell Biol. 74, 219–242.
Jaffe, L.A., Norris, R., Freudzon, M., Ratzan, W.J., Mehlmann, L.M., in press.
Microinjection of follicle-enclosed mouse oocytes. Meth. Mol. Biol.
Jones, T.L.Z., Degtyarev, M.Y., Backlund, P.S., 1997. The stoichiometry of
Gαs palmitoylation in its basal and activated states. Biochemistry 36,
7185–7191.
Kalinowski, R.R., Berlot, C.H., Jones, T.L.Z., Ross, L.F., Jaffe, L.A.,
Mehlmann, L.M., 2004. Maintenance of meiotic prophase arrest in
vertebrate oocytes by a Gs protein-mediated pathway. Dev. Biol. 267, 1–13.
Kidder, G.M., Mhawi, A.A., 2002. Gap junctions and ovarian folliculogenesis.
Reproduction 123, 613–620.
Ledent, C., Demeestere, I., Blum, D., Petermans, J., Hamalainen, T., Smits, G.,
Vassart, G., 2005. Premature ovarian aging in mice deficient for Gpr3. Proc.
Natl. Acad. Sci. U. S. A. 102, 8922–8926.
Levis, M.J., Bourne, H.R., 1992. Activation of the α subunit of Gs in intact cells
alters its abundance, rate of degradation, and membrane avidity. J. Cell Biol.
119, 1297–1307.
Lincoln, A.J., Wickramasinghe, D., Stein, P., Schultz, R.M., Palko, M.E.,
De Miguel, M.P., Tessarollo, L., Donovan, P.J., 2002. Cdc25b phosphatase
is required for resumption of meiosis during oocyte maturation. Nat. Genet.
30, 446–449.
Marrari, Y., Crouthamel, M., Irannejad, R., Wedegaertner, P.B., 2007. Assembly
and trafficking of heterotrimeric G Proteins. Biochemistry 46, 7665–7677.
Masciarelli, S., Horner, K., Liu, C., Park, S.H., Hinckley, M., Hockman, S.,
Nedachi, T., Jin, C., Conti, M., Manganiello, V., 2004. Cyclic nucleotide
phosphodiesterase 3A-deficient mice as a model of female infertility. J. Clin.
Invest. 114, 196–205.
Mehlmann, L.M., 2005a. Oocyte-specific expression of Gpr3 is required for the
maintenance of meiotic arrest in mouse oocytes. Dev. Biol. 288, 397–404.
Mehlmann, L.M., 2005b. Stops and starts in mammalian oocytes: recent
advances in understanding the regulation of meiotic arrest and oocyte
maturation. Reproduction 130, 791–799.
Mehlmann, L.M., Jones, T.L.Z., Jaffe, L.A., 2002. Meiotic arrest in the mouse
follicle maintained by a Gs protein in the oocyte. Science 297, 1343–1345.
Mehlmann, L.M., Saeki, Y., Tanaka, S., Brennan, T.J., Evsikov, A.V., Pendola,
F.L., Knowles, B.B., Eppig, J.J., Jaffe, L.A., 2004. The Gs-linked receptor
GPR3 maintains meiotic arrest in mammalian oocytes. Science 306,
1947–1950.
249R.P. Norris et al. / Developmental Biology 310 (2007) 240–249Mehlmann, L.M., Kalinowski, R.R., Ross, L.F., Parlow, A.F., Hewlett, E.L.,
Jaffe, L.A., 2006. Meiotic resumption in response to luteinizing hormone
is independent of a Gi family G protein or calcium in the mouse oocyte.
Dev. Biol. 299, 345–355.
Nair, B.G., Parikh, B., Milligan, G., Patel, T.B., 1990. Gsα mediates epidermal
growth factor-elicited stimulation of rat cardiac adenylate cyclase. J. Biol.
Chem. 265, 21317–21322.
Nikolaev, V.O., Lohse, M.J., 2006. Monitoring of cAMP synthesis and
degradation in living cells. Physiology 21, 86–92.
Park, J.Y., Su, Y.Q., Ariga, M., Law, E., Jin, S.L.C., Conti, M., 2004. EGF-like
growth factors as mediators of LH action in the ovulatory follicle. Science
303, 682–684.
Pincus, G., Enzmann, E.V., 1935. The comparative behavior of mammalian eggs
in vivo and in vitro. J. Exp. Med. 62, 665–675.
Rasenick, M.M., Wheeler, G.L., Bitensky, M.W., Kosack, C.M., Malina, R.L.,
Stein, P.J., 1984. Photoaffinity identification of colchicine-solubilized
regulatory subunit from rat brain adenylate cyclase. J. Neurochem. 43,
1447–1454.
Richard, F.J., Tsafriri, A., Conti, M., 2001. Role of phosphodiesterase type 3A in
rat oocyte maturation. Biol. Reprod. 65, 1444–1451.
Schultz, R.M., Montgomery, R.R., Belanoff, J.R., 1983. Regulation of mouse
oocyte meiotic maturation: Implication of a decrease in oocyte cAMP and
protein dephosphorylation in commitment to resume meiosis. Dev. Biol. 97,
264–273.
Sela-Abramovich, S., Edry, I., Galiani, D., Nevo, N., Dekel, N., 2006.
Disruption of gap junctional communication within the ovarian follicle
induces oocyte maturation. Endocrinology 147, 2280–2286.
Shimada, M., Hernandez-Gonzales, I., Gonzalez-Robayna, I., Richards, J.S.,
2006. Paracrine and autocrine regulation of epidermal growth factor-like
factors in cumulus oocyte complexes and granulosa cells: key roles for
prostaglandin synthase 2 and progesterone receptor. Mol. Endocrinol. 20,
1352–1365.Simon, A.M., Goodenough, D.A., Li, E., Paul, D.L., 1997. Female infertility in
mice lacking connexin 37. Nature 385, 525–529.
Simonds, W.F., Goldsmith, P.K., Woodard, C.J., Unson, C.G., Spiegel, A.M.,
1989. Receptor and effector interactions of Gs. Functional studies with
antibodies to theαs carboxyl-terminal decapeptide. FEBSLett. 249, 189–194.
Tanaka, S., Ishii, K., Kasai, K., Yoon, S.O., Saeki, Y., 2007. Neural expression
of G protein-coupled receptors GPR3, GPR6, and GPR12 up-regulates
cyclic AMP levels and promotes neurite outgrowth. J. Biol. Chem. 282,
10506–10515.
Thiyagarajan, M.M., Bigras, E., Van Tol, E., Hebert, T.E., Evanko, D.S.,
Wedegaertner, P.B., 2002. Activation-induced subcellular redistribution of
Gαs is dependent upon its unique N-terminus. Biochemistry 41, 9470–9484.
Törnell, J., Billig, H., Hillensjö, T., 1990. Resumption of rat oocyte meiosis is
paralleled by a decrease in guanosine 3′,5′-cyclic monophosphate (cGMP)
and is inhibited by microinjection of cGMP. Acta Physiol. Scand. 139,
511–517.
Uhlenbrock, K., Gassenhuber, H., Kostenis, E., 2002. Sphingosine 1-phosphate
is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively
active G protein-coupled receptors. Cell. Signal. 14, 941–953.
Veitch, G.I., Gittens, J.E.I., Shao, Q., Laird, D.W., Kidder, G.M., 2004. Selective
assembly of connexin37 into heterocellular gap junctions at the oocyte/
granulosa cell interface. J. Cell. Sci. 117, 2699–2707.
Wedegaertner, P.B., Bourne, H.R., 1994. Activation and depalmitoylation of
Gsα. Cell 77, 1063–1070.
Wedegaertner, P.B., Bourne, H.R., von Zastrow, M., 1996. Activation-induced
subcellular redistribution of Gsα. Mol. Biol. Cell 7, 1225–1233.
Wieland, T., Lutz, S., Chidiac, P., 2007. Regulators of G protein signalling: a
spotlight on emerging functions in the cardiovascular system. Curr. Opin.
Pharmacol. 7, 1–7.
Yu, J.-Z., Rasenick, M.M., 2002. Real-time visualization of a fluorescent Gαs:
dissociation of the activated G protein from plasma membrane. Mol.
Pharmacol. 61, 352–359.
